The co-founder of Lipitor wants to start a new business in Ann Arbor, sending signals through the biotech community that key talent and investment will remain after Pfizer Inc. closes its doors. Roger ...

NEW YORK Pfizer’s U.S. revenue decreased in 2007 as competition in the cholesterol market helped lead to an 8 percent decline in revenues for the world’s best selling drug, Lipitor. The company’s 2007 ...

Pfizer reported lower-than-expected quarterly earnings Wednesday on competition with generics, and said global sales of cholesterol fighter Lipitor fell 13% amid slipping demand for the company's ...

NEW YORK — Pfizer Inc.’s Lipitor, which has been steadily losing market share, faces more pressure as health plans unleash a new wave of programs promoting the use of generic cholesterol drugs.

NEW YORK, March 7 (UPI) -- U.S. drug powerhouse Pfizer said Wednesday its top-selling cholesterol drug Lipitor has been approved for five new uses for heart disease. The new uses include reducing the ...

Pfizer has mounted an aggressive campaign for its cholesterol-reducing drug Lipitor that includes advertisements, lobbying efforts and a paid speaking tour by a former secretary of the Department of ...

NEW YORK – Drugmaker Pfizer Inc. said Wednesday its second-quarter profit fell 48 percent year-over-year, hurt by the loss of patent exclusivity for its Zoloft and Norvasc drugs and by sluggish sales ...

Pfizer's Lipitor commercial, which featured Dr. Robert Jarvik. Both Pfizer and Jarvik drew fire from critics who questioned Dr. Jarvik's endorsement of a medication they argued he is neither licensed ...

NEW YORK (CNNMoney.com) -- Patients who switched from the cholesterol-cutting drug Lipitor to the competitor simvastatin increased their risk of suffering heart attacks and strokes, according to a ...